TP53 and acute myeloid leukemia: The high frequency of complex karyotype among TP53‐mutant AML patients may reflect a higher cytogenetic instability and higher tolerance to gross karyotypic aberrancies in leukemic cells lacking functional wild‐type TP53 protein.